md-medicaldata

Authors

 

Džemail S. Detanac¹ , Mehmed Mujdragić¹ , Dženana A. Detanac¹ , Mersudin Mulić² , Biljana Lazović <sup>3

1</sup>General hospital Novi Pazar, Novi Pazar, Serbia
²State university Novi Pazar, Serbia
³Clinical center Zemun, Belgrade, Serbia

 

UDK: 616.379-008.64-06:617.586

The paper was received / Rad primljen: 19.01.2020.

Accepted / Rad prihvaćen: 20.02.2020.

 

Correspondence to:

Džemail S. Detanac
General hospital Novi Pazar,
St Generala Živkovića 1
Novi Pazar, Serbia
mob tel +381 64 6370 412
e-mail: dzemail.detanac@gmail.com

 

 

Abstract

 

Diabetes mellitus (DM) is a chronic disease of global significance with a growing number of patients. Diabetic foot syndrome (DFS) is defined as ulceration of the foot which develops as a result of peripheral neuropathy, ischemia as a result of peripheral vascular disease,  repetitive trauma, and infection. It can be classified as the neuropathic and ischemic foot and the treatment is always multidisciplinary. Patients with DM lower limb amputations and ulceration rates can be reduced by the implementation of therapeutic and preventative foot care strategies.

 

 

Key words:

Diabetic foot syndrome, Diabetes mellitus, Hyperglycemia, diabetic neuropathy, peripheral vascular disease

 

 

Sažetak

 

Dijabetes melitus (DM) je hronična bolest od globalnog značaja, s rastućim brojem bolesnika. Sindrom dijabetesnog stopala (DFS) definiše se kao ulceracija stopala koja se razvija kao rezultat periferne neuropatije, ishemije kao rezultat periferne vaskularne bolesti, ponavljajuće trauma i infekcije. Može se klasifikovati kao neuropatsko i ishemijsko stopalo, a lečenje je uvek multidisciplinarno. Procenat amputacija donjih ekstremiteta i ulceracija kod pacijenata sa dijabetes melitusom, može se smanjiti primenom terapijskih i preventivnih mera nege stopala.

 

 

Ključne reči:

sindrom dijabetesnog stopala, dijabetes melitus, hiperglikemija, dijabetesna neuropatija, periferna vaskularna bolest

 

 

References:

1. Al-Busaidi IS, Abdulhadi NN, Coppell KJ. Care of patients with diabetic foot disease in Oman. Sultan QaboosUniv Med J. 2016;16(3):e270-6.
2. International Diabetes Federation. IDF Diabetes Atlas, 7th ed. Watermael-Boitsfort, Belgium: International Diabetes Federation, 2015. Pp. 50–120.
3. https://www.idf.org/our-network/regions-members/europe/members/156-serbia.html
4. Jowitt L. Ethnicity and type 2 diabetes in Asian Indian migrants in Auckland, New Zealand. Sanamed. 2014; 9(3):253-63.
5. Mosa O, Rizk M, Ahmed A. Microalbuminuria besides to urinary enzymatic protein levels increase in diabetic kidney disease with type II diabetics. Sanamed.2018;13(2): 145-52.
6. Amin N, Doupis J. Diabetic foot disease: From the evaluation of the "foot at risk" to the novel diabetic ulcer treatment modalities. World J Diabetes.2016;7(7):153-64.
7. Tuttolomondo A, Maida C, Pinto A. Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients. J Diabetes Res. 2015;2015:268390.
8. Grujić-Vujmilović D, Gavrić Ž. Quality of life of patients with diabetes mellitus: Social domain of health. Sanamed. 2014; 9(2):151-9.
9. Jeffcoate WJ, Macfarlane RM, Fletcher EM. The description and classification of diabetic foot lesions. Diabet Med.1993;10(7):676–9.
10. vanNetten JJ, Baba M, Lazzarini PA. Epidemiology of diabetic foot disease and diabetes-related lower-extremity amputation in Australia: a systematic review protocol. Syst Rev. 2017;6(1):101.
11. Rodrigues BT, Vangaveti VN, Malabu UH. Prevalence and risk factors for diabetic lower limb amputation: a clinic-based case control study. J Diabetes Res. 2016:5941957.
12. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North-West Diabetes Foot Care Study: incidence of and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19(5):377-84.
13. Rathur HM, Boulton AJ. The diabetic foot. ClinDermatol. 2007;25: 109-20.
14. Bartus CL, Margolis DJ. Reducing the incidence of foot ulceration and amputation in diabetes. CurrDiab Rep. 2004; 4: 413-8.
15. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22(3): 382-7.
16. Chammas NK, Hill RLR, Edmonds ME. Increased mortality in diabetic foot ulcer patients: the significance of ulcer type. J Diabetes Res. 2016; 2016: 2879809.
17. Armstrong DG, Wrobel J, Robbins JM. Guest editorial: are diabetes-related wounds and amputations worse than cancer. Int Wound J. 2007;4(4):286-7.
18. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. Jama. 2005;293(2):217-28.
19. Ibrahim A. IDF Clinical Practice Recommendation on the Diabetic Foot: A guide for healthcare professionals 2017;127:285-287. 
20. Boulton AJM, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R et al. Diabetic neuropathies. Diabetes Care.2005; 28 (4) 956-62.
21. Bruhn-Olszewska B, Korzon-Burakowska A, Gabig-Cimińska M, Olszewski P, Węgrzyn A, Jakóbkiewicz-Banecka J. Molecular factors involved in the development of diabetic foot syndrome. ActaBiochim Pol. 2012;59(4):507-13.
22. Cade WT. Diabetes related microvascular and macrovascular diseases in the physical therapy setting. Physical Therapy. 2008;88(11):1322-35.
23. Dohmen A, Eder S, Euringer W, Zeller T, Beyersdorf F. Chronic critical limb ischemia. DeutschesÄrzteblatt International. 2012;109(6):95-101.
24. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States. Circulation. 2004;110(6):738-43.
25. deMacedo GM, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. DiabetolMetabSynr. 2016;8(1):63.
26. Galdeano F, Zaccaria S, Parra V, Giannini ME, Salomón S. Cutaneous manifestations of diabetes mellitus: clinical meaning. Dermatología Argent. 2013;16:117–21.
27. Djelic M, Mazic S, Tepsic J, Nesic D, Lazovic B, Radovanovic D, Sumarac M, Micic D. Effect of acute exercise on serum growth hormone and fatty acid levels in elite male water polo players. Archives of Biological Sciences 2014; 66(1):355-361
28. Kish TD, Chang MH, Fung HB. Treatment of skin and soft tissue infections in theelderly: A review. Am J GeriatrPharmacother. 2010; 8:485–513.
29. Bokan V. Risk factors for diabetic foot ulceration-foot deformity and neuropathy. ActamedicaMedianae. 2010; 49(4):19-22.
30. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells.Stem Cells Dev. 2012;21(14):2724-52.

PDF Detanac S. Dž. et al • MD-Medical Data 2020;12(1): 021-024